Modulight Spotlights: LASER-SHARP RESEARCH – April 2024
Modulight Spotlights: LASER-SHARP RESEARCH – April 2024 Read More »
ML7710-PDT
ML7710 for photoactivated treatment of lung cancer
Deadliest cancer Precision with photoactivation Photoimmunotherapy with ML7710 offers a clinical therapeutic option for NSCLC patients even with advanced disease stage. Besides laser light, this therapy involves photoactivated drug, which can be activated precisely at the tumor site with laser fibers, hence minimizing drug effects to healthy tissues. Smaller invasiveness compared to surgery can enable
ML7710 for photoactivated treatment of lung cancer Read More »
Photodynamic Therapy of Non–Small Cell Lung Cancer. Narrative Review and Future Directions
Published in: Annals of the American Thoracic Society Authors: Gal Shafirstein 1,2, Athar Battoo 3, Kassem Harris 4, Heinz Baumann 5, Sandra O. Gollnick 1,6, Joerg Lindenmann 1,7, and Chukwumere E. Nwogu 3 1Photodynamic Therapy Center 2Department of Cell Stress Biology 3Department of Thoracic Surgery 4Department of Medicine, Interventional Pulmonology 5Department of Molecular and Cellular Biology, and 6Department of Immunology, Roswell Park Cancer Institute, Buffalo, New York; and 7Division